TrialNature medicine2022

Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial.

Robert H Baloh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.